Photography: David Stobbe

The quest for a solution

Posted on

USask’s VIDO emerges as Canada’s leader in vaccine development.

On Dec. 31, 2019, the World Health Organization (WHO) was alerted to a mysterious case of pneumonia with an unknown cause on the other side of the world.

Dr. Volker Gerdts, director and CEO of USask’s Vaccine and Infectious Disease Organization (VIDO), had been in his role for just under a year when the news broke. As a scientist with a veterinary degree and doctorate in virology and immunology from his home country of Germany, he was not surprised….

https://news.usask.ca/articles/research/2021/greenandwhite-the-quest-for-a-solution.php

 

Read More Impact Stories

Posted on
McGill-developed device offers 100 per cent accuracy in as little as 10 minutes, and can be configured to detect a [...]
Posted on
This content is available in French only.
Posted on
The University of Toronto and Moderna, Inc. known for its mRNA-based COVID-19 vaccine plan to work together to develop new [...]